Date of publication: December 15,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/FR/06/12/01
Member State
France
Date of Acknowledgement
10/11/2006 00:00:00
Title of the Project
Field trials of genetically
modified herbicide tolerant maize event GA21 to be carried out
in France between 2007 and 2009
Proposed period of release:
01/04/2007 00:00:00 to 30/11/2009
00:00:00
Name of the Institute(s) or
Company(ies)
Syngenta Seeds SAS, Syngenta Seeds SAS
on behalf of Syngenta Crop Protection AG, Basel Switzerland and
all affiliated companies;
3. Is the same GMPt release planned
elsewhere in the Community?
Yes:
Has the same GMPt been notified
elsewhere by the same notifier?
Yes
If yes, notification number(s):
Other notifications
Syngenta has performed field trials of
GA21 in Spain, France, Czech Republic , Romania and Brazil.
Syngenta has approval to perform field trials in South Africa.
NOTE: Event GA21 has been approved for commercial cultivation in
the USA, Canada, Argentina and Japan. The event is currently
cultivated in the USA and Canada.
Genetically modified plant
Complete name of the recipient or
parental plant(s)
|
Common Name |
Family Name |
Genus |
Species |
Subspecies |
Cultivar/breeding line |
| maize |
poaceae |
zea |
zea mays |
mays |
|
2. Description of the traits and
characteristics which have been introduced or modified,
including marker genes and previous modifications:
A gene encoding a protein capable of
conferring a herbicide tolerant characteristic.
Genetic modification
3. Type of genetic modification:
Insertion;
In case of insertion of genetic
material, give the source and intended function of each
constituent fragment of the region to be inserted:
Regulatory sequences: Promoter, intron
and exon sequences derived from rice. The function of these
sequences is to control expression of the herbicide tolerance
gene.
Optimised transit peptide: N-terminal optimised transit peptide
sequence constructed based on transit peptide sequences from
maize and sunflower.
Herbicide tolerance gene: epsps
(5-enolpyruvylshikimate-3-phosphate synthase) gene derived from
maize. The function of the product of this gene is to confer
tolerance to herbicide products containing glyphosate.
NOS terminator: Termination sequence of the nopaline synthase
gene, isolated from Agrobacterium tumefaciens. The function of
this sequence is to signal termination of the herbicide tolerant
gene expression.
6. Brief description of the method
used for the genetic modification:
Event GA21 was produced via
microprojectile bombardment of maize suspension culture cells.
7. If the recipient or parental plant
is a forest tree species, describe ways and extent of
dissemination and specific factors affecting dissemination:
Not applicable as the recipient or
parental plant is not a forest tree species.
Experimental Release
1. Purpose of the release:
The purpose of the field releases is to
gain further information relating to the use of herbicide
products containing glyphosate under French conditions and to
produce maize for comparative analysis.
2. Geographical location of the site:
The releases are planned at several
locations in France in 2007 in Aquitaine, Charente-Poitou,
Centre and Midi-Pyrénées.
3. Size of the site (m2):
Each year, there could be up to 8
sites; each site will have 5000m² sown with the genetically
modified maize subject of this notification (GA21).
4. Relevant data regarding previous
releases carried out with the same GM-plant, if any,
specifically related to the potential environmental and human
health impacts from the release:
Evidence from previous field trials in
the USA and Europe suggests that the genetically modified lines
do not differ from the recipient plant in mode or rate of
reproduction, dissemination or survivability of the plant. Event
GA21 has been approved for commercial cultivation in the USA,
Canada, Argentina and Japan. The event is currently cultivated
in the USA and Canada with no adverse effects effects to the
environment or on human health reported.
Environmental Impact and Risk
Management
Summary of the potential environmental
impact from the release of the GMPts:
An Environmental Risk Assessment has
been completed and submitted with the application. In summary,
no immediate or delayed adverse effects as a result of the
direct and indirect interaction of the genetically modified
maize with the environment when compared to non-modified maize
have been identified.
Brief description of any measures
taken for the management of risks:
The field trials will be no less than
400 m from other maize fields and will be surrounded by a border
of conventional maize.
The products from the trials may be used for analysis and will
not be used for human food or animal feed.
Plant material remaining after harvest will be ground and
incorporated into the soil.
The sites will be monitored for one year after the release and
any volunteer maize appearing will be eliminated before
flowering. During this year, maize will not be grown on the
trial sites.
Summary of foreseen field trial
studies focused to gain new data on environmental and human
health impact from the release:
The trials have not been designed to
specifically gain new data on the environment and human health
impact of the release. They will also allow the further
assessment of of the use of herbicide products containing
glyphosate under European and French conditions.
Final report
-
European Commission administrative
information
Consent given by the Competent
Authority:
Not known |
